Table 5.
The effect of infection history on antibody titer in 3 vaccine types.
Vaccine type | After the first dose | After second dose | ||||
---|---|---|---|---|---|---|
Antibody titer (BAU/ml): Median (IQR 25–75) | Antibody titer (BAU/ml): Median (IQR 25–75) | |||||
With Inf.h | Without inf.h | P-value | With Inf.h | Without inf.h | P-value | |
AstraZeneca | 796.8 (376.0–820.0) | 152.0 (60.8–387.2) | < 0.001 | 419.2 (617.6–411.2) | 366.4 (252.8–412.8) | < 0.001 |
COVIran Barekat | 150.4 (51.2–323.2) | 105.6 (16.0–278.4) | 0.232 | 163.2 (64.8–381.6) | 192.0 (72.0–297.6) | 0.800 |
Sinopharm | 275.2 (166.4–315.2) | 57.6 (15.2–262.4) | 0.003 | 264.0 (134.4–389.6) | 176.0 (72.0–300.8) | 0.159 |
Overall | 320.0 (212.8–796.8) | 105.6 (20.0–299.2) | < 0.001 | 384.0 (211.2–422.4) | 235.2 (96.0–371.2) | 0.002 |
Inf.h, infection history.